Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Open access
3,567
Views
27
CrossRef citations to date
0
Altmetric
Research Article
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
Baozhen ZhangLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Guogang ChengLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Mingbin ZhengGuangdong Key Laboratory of Nanomedicine, CAS Key Lab for Health Informatics, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Jinyu HanLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Baobei WangLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Mengxia LiLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Jie ChenLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Tianxia XiaoLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Jian ZhangLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; View further author information
, Lintao CaiGuangdong Key Laboratory of Nanomedicine, CAS Key Lab for Health Informatics, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Correspondence[email protected]
View further author information
, View further author information
Shoujun LiGuangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases, Guangzhou, China; ;College of Veterinary Medicine, South China Agricultural University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
& View further author information
Xiujun FanLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Correspondence[email protected]
http://orcid.org/0000-0003-3322-1857View further author information
Pages 461-471
|
Received 20 Dec 2017, Accepted 29 Jan 2018, Published online: 09 Feb 2018
Related Research Data
Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA
Source:
Springer Science and Business Media LLC
Structural and Functional Insight into How thePlasmodium falciparumVAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
Source:
Taylor & Francis
The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Identification of Multiple Chondroitin Sulfate A (CSA)–Binding Domains in thevar2CSAGene Transcribed in CSA‐Binding Parasites
Source:
Oxford University Press (OUP)
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
Source:
Taylor & Francis
Noninvasive Monitoring of Placenta-Specific Transgene Expression by Bioluminescence Imaging
Source:
Public Library of Science (PLoS)
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
Source:
American Chemical Society (ACS)
Performance of Doxorubicin-Conjugated Gold Nanoparticles: Regulation of Drug Location
Source:
American Chemical Society (ACS)
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.
Source:
American Association for Cancer Research (AACR)
Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.
Source:
Rockefeller University Press
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Source:
American Association for the Advancement of Science (AAAS)
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications
Source:
American Society for Clinical Investigation
Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets
Source:
Elsevier BV
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Source:
Elsevier BV
Formulation of Drugs in Block Copolymer Micelles: Drug Loading and Release
Source:
Bentham Science Publishers Ltd.
Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives
Source:
Future Medicine Ltd
Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs
Source:
Elsevier BV
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
Source:
American Chemical Society (ACS)
Nanoparticles containing insoluble drug for cancer therapy
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Choriocarcinoma with brain, lung and vaginal metastases successfully treated without brain radiation or intrathecal chemotherapy: A case report
Source:
Elsevier BV
Quick Synthesis of Lipid−Polymer Hybrid Nanoparticles with Low Polydispersity Using a Single-Step Sonication Method
Source:
American Chemical Society (ACS)
Nanomedicine-Challenge and Perspectives
Source:
Wiley
Gestational Trophoblastic Disease
Source:
Elsevier BV
Cancer nanotechnology: opportunities and challenges.
Source:
Springer Science and Business Media LLC
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles
Source:
American Association for Cancer Research (AACR)
Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.